SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-056378
Filing Date
2020-12-08
Accepted
2020-12-08 08:00:23
Documents
12
Period of Report
2020-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K scyx-8k_20201202.htm   iXBRL 8-K 43227
  Complete submission text file 0001564590-20-056378.txt   171744

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA scyx-20201202.xsd EX-101.SCH 5776
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20201202_lab.xml EX-101.LAB 19474
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20201202_pre.xml EX-101.PRE 11630
5 EXTRACTED XBRL INSTANCE DOCUMENT scyx-8k_20201202_htm.xml XML 3544
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36365 | Film No.: 201374420
SIC: 2834 Pharmaceutical Preparations